We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reviews Bracco CardioGen-82 for Potential High Radiation Doses
FDA Reviews Bracco CardioGen-82 for Potential High Radiation Doses
July 22, 2011
Patients who undergo cardiac positron emission tomography (PET) scans with Bracco Diagnostics’ CardioGen-82 face an inadvertent potential risk for increased radiation exposure, the FDA says, noting it is actively investigating the root cause of the radiation increase.